Physician profile
Lily Babayev
NPI 1851307136
$7,879.65
in general payments reported to CMS, 2019-2025
37 companies · $624 in 2025
The $624 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,256 · 2020: $1,115 · 2021: $1,300 · 2022: $1,296 · 2023: $1,290 · 2024: $1,000 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,914.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,370.13 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,236.62 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,100.51 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $866.99 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Pfizer INC. | $643.91 | 2019-2025 | |
| Lilly USA, LLC | $471.62 | 2019-2025 | Mounjaro |
| Merck Sharp & Dohme LLC | $214.99 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.39 | 2020-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $160.19 | 2019-2023 | Eliquis |
| Exact Sciences Corporation | $138.97 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $129.00 | 2022-2024 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $114.01 | 2019-2020 | |
| Boston Scientific Corporation | $112.95 | 2020-2022 | |
| Allergan, INC. | $111.25 | 2019 | |
| Astellas Pharma US INC | $95.37 | 2019-2023 | Veozah |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lily Babayev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.